Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer

BACKGROUND: Inflammatory mammary cancer (IMC), the counterpart of human inflammatory breast cancer (IBC), is the deadliest form of canine mammary tumors. IMC patients lack specific therapy and have poor outcomes. This proof-of-principle preclinical study evaluated the efficacy, safety, and effect on...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso-Miguel, Daniel, Valdivia, Guillermo, Guerrera, Diego, Perez-Alenza, Maria Dolores, Pantelyushin, Stanislav, Alonso-Diez, Angela, Beiss, Veronique, Fiering, Steven, Steinmetz, Nicole F, Suarez-Redondo, Maria, vom Berg, Johannes, Peña, Laura, Arias-Pulido, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919457/
https://www.ncbi.nlm.nih.gov/pubmed/35277459
http://dx.doi.org/10.1136/jitc-2021-004044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919457/
https://www.ncbi.nlm.nih.gov/pubmed/35277459
http://dx.doi.org/10.1136/jitc-2021-004044

Ejemplares similares